Metabolic effects of hypoglycemic sulfonylureas. IV. Interference of sulfonylureas with mitochondrial oxidative phosphorylation.
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D002271:Carbutamide / Q000494:pharmacology; D002747:Chlorpropamide / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005905:Glyburide / Q000494:pharmacology; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D008297:Male; D008930:Mitochondria, Liver / Q000378:metabolism*; D009840:Oligomycins / Q000494:pharmacology; D010085:Oxidative Phosphorylation / Q000187:drug effects*; D010101:Oxygen Consumption / Q000187:drug effects; D051381:Rats; D013386:Succinates / Q000378:metabolism; D013453:Sulfonylurea Compounds / Q000494:pharmacology*
D004140:Dinitrophenols; D007004:Hypoglycemic Agents; D009840:Oligomycins; D013386:Succinates; D013453:Sulfonylurea Compounds; D000255:Adenosine Triphosphate; D002271:Carbutamide; D005905:Glyburide; D002747:Chlorpropamide